Financhill
Back

bluebird bio Stock Predictions

bluebird bio Stock Forecast

  • Is bluebird bio Stock Undervalued?
    The current bluebird bio [BLUE] share price is $0.35. The Score for BLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will bluebird bio Stock Go Up Next Year?

Data Unavailable

bluebird bio Stock Rating

Data Unavailable

bluebird bio Stock Price History

Is BLUE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bluebirdbio.com

52-Week Data

52-Week High:
5.53
52-Week Low:
0.29

Prediction Charts

Market Cap:
68.07M
Price in USD:
0.35
Volume:
10.35M
Beta:
1.25

Technical Analysis

SMA50:
0.46
SMA100:
0.68
SMA200:
0.90
52-Wk Change:
-90.76%

Stock Predictions

  • Is bluebird bio stock public?
    Yes, bluebird bio is a publicly traded company.
  • What is the bluebird bio stock quote today?
    The bluebird bio stock price is 0.35 USD today.
  • How to buy bluebird bio stock online?
    You can buy bluebird bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 0.46 0.45 0.47 0.45
Nov-6 0.45 0.44 0.46 0.43
Nov-7 0.43 0.38 0.43 0.34
Nov-8 0.38 0.41 0.42 0.38
Nov-11 0.42 0.40 0.43 0.40
Nov-12 0.40 0.39 0.43 0.39
Nov-13 0.39 0.38 0.42 0.37
Nov-14 0.37 0.36 0.40 0.35
Nov-15 0.37 0.32 0.37 0.32
Nov-18 0.32 0.33 0.34 0.32
Nov-19 0.32 0.31 0.33 0.30
Nov-20 0.31 0.30 0.32 0.29
Nov-21 0.31 0.30 0.31 0.29
Nov-22 0.30 0.35 0.36 0.30

bluebird bio Earnings

Data Unavailable

bluebird bio Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.66 per share.

* bluebird bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.